BLOG POST

GSK Says More Vaccines in India Because of Intellectual Property

By
September 07, 2005
An interesting article in the Hindu Business Line looks at the growing use of vaccines in India.Here is what caught my eye:
The reason why global drug/vaccine companies are bringing more products to India is because of the open market and the product-patent regime effective from this year, he [Dr Sanjoy K. Datta, Medical Director with GSK Biologicals] says.

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.

More Reading

Gavi worker giving vaccine to newborn child
Blog Post
Five Areas for Reform in Gavi 6.0
Janeen Madan Keller
and
Morgan Pincombe
April 08, 2024
CGD NOTES
Opportunities for a New Compact between Gavi and Partner Countries
Anastassia Demeshko
and
Tom Drake
April 08, 2024
A professional from the health department applies a dose of the vaccine against covid-19
Blog Post
How Gavi Can Address Undervaccination Challenges in Middle-Income Countries
Rachel Silverman Bonnifield et al.
April 08, 2024
POLICY PAPERS
Opportunities for Gavi to Enhance Vaccine Access in Middle-Income Countries
Rachel Silverman Bonnifield et al.
April 08, 2024